Life-threatening infection with multiresistant Staphylococcus epidermidis in a patient with end-stage renal disease: Cure with chloramphenicol and quinupristin/dalfopristin (RP 59500)

Infection

Volumn 25, Issue 4, 1997, Pages 252-254

  Mundlein E ^a   Von Baum, H ^a   Geiss, H K ^a   Springsklee, M ^b   Zeier, M ^a   Andrassy, K ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Rhone Poulenc Rorer GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ARTICLE; CASE REPORT; EYE INFECTION; HEPATITIS; HUMAN; HUMAN TISSUE; INTERVERTEBRAL DISK DEGENERATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUNG INFECTION; MALE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CHLORAMPHENICOL; DRUG RESISTANCE, MULTIPLE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REOPERATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VIRGINIAMYCIN;

EID: 0030812425     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01713157     Document Type: Article

References (11)

1. Mc Caig, L. F., Hughes, J. M.: Trends in antimicrobial drug prescribing among the office-based physicians in the United States. JAMA 273 (1995) 214-219.
2. Tenover, F., Hughes, J. M.: The challenges of emerging infectious diseases: development and spread of multiply-resistant bacterial pathogens. JAMA 275 (1996) 300-304.
3. Lynn, W., Clutlerbuck, E., Want, S., Markides, V., Lacey, S., Rogers, T., Cohen, J.: Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin. Lancet 344 (1994) 1025-1026.
4. Kropec, A., Daschner, F. D.: Penetration into tissues of various drugs active against gram-positive bacteria. J. Antimicrob. Chemother. 27 (Suppl. B) (1991) 9-15.
5. Exner, K., Lang, E., Borsche, A., Lemperle, G.: Efficacy, tolerability and pharmaceutics of teicoplanin in patients undergoing breast surgery. Eur. J. Surg. (Suppl. 567) (1992) 33-38.
6. Grüneberg, R. N., Wilson, A. P. R.: Dosage recommendations for teicoplanin: what have we learned? Chemotherapie J. 5 (Suppl. 11) (1996) 13-15.
7. Chatenoud, L.: Effects of chronic renal failure on the immune response. In: Cameron, S., Davison, A. M., Grünfeld, J. P., Ritz, E. (eds.): Oxford textbook of clinical nephrology. 2nd ed. Oxford University Press, Oxford 1992, pp. 1312-1317.
8. Bommer, J.: Medical complications of the long-term dialysis patient. In: Cameron, S., Davison, A. M., Grünfeld, J. P., Ritz, E. (eds.): Oxford textbook of clinical nephrology. 2nd ed. Oxford University Press, Oxford 1992, pp. 1436-1439.
9. Font, J., Bruguera, M., Perez-Villa, F., Ingelmo, M.: Hepatic fibrinring granulomas caused by Staphylococcus epidermidis generalized infection. Gastroenterology 93 (1987) 1449-1451.
10. Casal, M. J., Ruiz Pilar, C. C.: Preliminary study of the in vitro activity of RP 59500 against Mycobacterium tuberculosis. 3rd ICMAS, Lisbon, 24-27 January (1996), abstr. 7.24.
11. Simon, C., Stille, W.: Antibiotika-Therapie in Klinik und Praxis. 7th ed. Schattauer, Stuttgart 1989, pp. 142-143.